1 active trials 1 recruiting 7 disease areas
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06362369 | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab… | Advanced Cancer | Recruiting | 2026-04-13 |
Colorectal Cancer (1) · Kidney Cancer (1) · Liver Cancer (1) · Lung Cancer (1) · Melanoma (1) · Mesothelioma (1) · Non-Small Cell Lung Cancer (NSCLC) (1)